By Associate Professor Min Jun

Conference Papers

Jun M; Sukkar L; Neuen B; Foote C; Rogers K; Kang A; Scaria A; Cass A; Pollock C; Sullivan D; Knight J; Gallagher M; Jardine M, 2018, 'ASSESSING THE RISK AND SEVERITY OF HOSPITALISATIONS ACCORDING TO LEVEL OF KIDNEY FUNCTION: AN EXTEND45 ANALYSIS', in NEPHROLOGY, WILEY, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Talbot B; Sukkar L; Smyth B; Jun M; Jardine M; Cass A; Walker R; Reith C; Hooi L; Gallagher M, 2018, 'CAUSE OF DEATH VARIES ACROSS AUSTRALIA, NEW ZEALAND AND MALAYSIA IN THOSE ON RENAL REPLACEMENT THERAPY - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in NEPHROLOGY, WILEY, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kang A; Sukkar L; Jun M; Foote C; Pecoits-Filho R; Neuen B; Scaria A; Baker J; Rogers K; Cass A; Pollock C; Sullivan D; Wong G; Knight J; Peiris D; Gallagher M; Jardine M, 2018, 'PREDICTORS OF CHRONIC KIDNEY DISEASE IN THE EXTEND45 STUDY: A NSW POPULATION-BASED STUDY', in NEPHROLOGY, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sukkar L; Kang A; Jun M; Foote C; Pecoitis-Filho R; Neuen B; Scaria A; Baker J; Rogers K; Cass A; Pollock C; Sullivan D; Wong G; Knight J; Peiris D; Gallagher M; Jardine M, 2018, 'SOCIOECONOMIC, DEMOGRAPHIC AND CLINICAL ASSOCIATIONS OF CHRONIC KIDNEY DISEASE IN DIABETES IN A POPULATION-BASED NSW COHORT: RESULTS FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sukkar L; Smyth B; Kang A; Jun M; Foote C; Rogers K; Scaria A; Neuen B; Gallagher M; Cass A; Sullivan D; Pollock C; Wong G; Knight J; Peiris D; Jardine M, 2018, 'THE MAKE-UP OF CARDIOVASCULAR DISEASE AS KIDNEY FUNCTION DECLINES: RESULTS FROM A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ohkuma T; Jun M; Esq MW; Chalmers J; Perkovic V; Rodgers A, 2018, 'Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, presented at 78th Scientific Sessions of the American-Diabetes-Association, FL, Orlando, 22 June 2018 - 26 June 2018, http://dx.doi.org/10.2337/db18-1483-P

Liyanage T; Ninomiya T; Wang A; Jun M; Neal B; Wong MG; Jardine M; Hillis G; Perkovic V, 2015, 'EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, CA, San Diego, pp. A1448 - A1448, presented at Scientific Session of the American-College-of-Cardiology (ACC), CA, San Diego, 14 March 2015 - 16 March 2015, http://dx.doi.org/10.1016/S0735-1097(15)61448-6

Conference Posters

Lam D; Scaria A; Gallagher M; Jun M, 2022, 'POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION', Vol. 7, pp. S111 - S112, http://dx.doi.org/10.1016/j.ekir.2022.01.273

Conference Abstracts

Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris K; Oshima M; Sattar N; Wurtz P; Jun M; Welsh P; Chalmers J; Woodward M, 2021, 'PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, pp. E45 - E45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000672599900120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jun M; Jardine M; Heerspink HL; Perkovic V; Badve S; Kotwal S; Gallagher M; Harris K; Chalmers J; Woodward M, 2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

TALBOT B; Sukkar L; Smyth B; Jun M; Jardine M; Cass A; Walker R; Reith C; Hooi L; Gallagher M, 2020, 'SUN-119 COMPARING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THREE COUNTRIES - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in Kidney International Reports, Elsevier BV, Vol. 5, pp. S250 - S250, http://dx.doi.org/10.1016/j.ekir.2020.02.646

YOUNG TK; HOCKHAM C; SUKKAR L; KANG AMY; JUN MIN; BAKER J; ROGERS K; CASS A; POLLOCK CA; SULLIVAN D; WONG G; JARDINE MJ, 2019, '1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1129-p

YOUNG TK; HOCKHAM C; SUKKAR L; KANG AMY; JUN MIN; BAKER J; ROGERS K; CASS A; POLLOCK CA; SULLIVAN D; WONG G; JARDINE MJ, 2019, '1130-P: Temporal Trends in Pharmacotherapy for Diabetes', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1130-p

Neuen B; Jardine M; Sukkar L; Kang A; Foote C; Rogers K; Scaria A; Cass A; Gallagher M; Jun M, 2018, 'INFECTION-RELATED HOSPITALISATIONS ACROSS DIFFERENT LEVELS OF KIDNEY FUNCTION: DATA FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 40 - 40

Foote C; Jun M; Sukkar L; Kang A; Rogers K; Baker J; Scaria A; Pecoits-Filho R; Cass A; Sullivan D; Gallagher M; Pollock C; Wong G; Knight J; Peiris D; Jardine M, 2018, 'KIDNEY FUNCTION, GLUCOSE-LOWERING TREATMENT AND HBA1C LEVELS IN PEOPLE WITH PREVALENT DIABETES: A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, Vol. 23, pp. 38 - 38

Zoungas S; Lambers Heerspink HJ; Chalmers J; Woodward M; Jun M; Cass A; MacMahon S; Cooper ME; Hamet P; Marre M; Mogensen CE; Perkovic V, 2011, 'Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S23 - S23, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Jun M; Lix L; Hemmelgarn BR, 2017, Direct oral anticoagulants and venous thromboembolism, Canadian Agency for Drugs and Technologies in Health

Preprints

Chan B; Varghese A; Badve SV; Pecoits-Filho R; Guedes M; Arnott C; Kozor R; O’Lone E; Jun M; Kotwal S; Block GA; Chertow GM; Solomon SD; Vaduganathan M; Neuen BL, 2024, Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis, , http://dx.doi.org/10.1101/2024.03.28.24305010

Neuen B; Jun M; Wick J; Kotwal S; Badve S; Jardine M; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley P, 2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, , http://dx.doi.org/10.1101/2023.06.26.23291881

Jun M; Wick J; Neuen B; Kotwal S; Badve S; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine M; Perkovic V; Gallagher M; Ronksley P, 2023, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, , http://dx.doi.org/10.1101/2023.06.18.23290762

Back to profile page